At ROVI, we have a diversified portfolio comprising around thirty of our own and licensed products.
Our portfolio has a defensive profile, since it has been practically unaffected by reference pricing
in Spain and no significant patents will expire until 2019.
Ameride®
Active Substance
Amiloride hydrochloride and hydrochlorothiazide
Therapeutic Area
Cardiovascular
License
ROVI propietary product
Bertanel®
Active Substance
Methotrexate
Therapeutic Area
Osteoarticular
License
License from Ebewe Pharma Gmbh Nfg. KG
BLUXAM
Active Substance
Hexacetonido de triamcinolona.
Therapeutic Area
Osteoarticular
License
License from Riemser Pharma Gmbh
ENOXAPARIN ROVI®
Active Substance
Sodium enoxaparin
Therapeutic Area
Thrombosis
License
ROVI propietary product
CALCIUM AND VITAMINE
D3 ROVI®
Active Substance
Calcium carbonate and cholecalciferol concentrate.
Therapeutic Area
Osteoarticular
License
ROVI propietary product
EXXIV®
Active Substance
Etoricoxib
Therapeutic Area
Osteoarticular and pain release
License
License from MSD
Prinivil®
Active Substance
Lisinopril
Therapeutic Area
Cardiovascular
License
ROVI propietary product
Rhodogil®
Active Substance
Spiramycin and Metronidazole
Therapeutic Area
Antibacterial
License
ROVI propietary product
GLUFAN®
Active Substance
Glucosamine hydrochloride
Therapeutic Area
Osteoarticular
License
ROVI propietary product
Hibor®
Active Substance
Sodium bemiparin
Therapeutic Area
Thrombosis
License
ROVI propietary product
Hirobriz®
Breezhaler®
Active Substance
Indacaterol maleate
Therapeutic Area
Pneumology
License
License from Novartis Europharm Limited
NEPARVIS®
Active Substance
Sacubitril/valsartan
Therapeutic Area
Cardiovascular
License
License from Novartis Europharm Limited
Medicebran®
Active Substance
Methylphenidate hydrochloride with inmediate release
Therapeutic Area
Central nervous system
License
License from MEDICE
Access to the physician´s guide and supportive material for monitoring of therapy through this link
Medikinet®
Active Substance
Methyilphenidate hydrochloride with modified release
Therapeutic Area
Central nervous system
License
License from MEDICE
Access to the physician´s guide and supportive material for monitoring of therapy through this link
Mysimba®
Active Substance
Naltrexone hydrochloride and bupropion hydrochloride. Prolonged release.
Therapeutic Area
Endocrinology
License
License from OREXIGEN
Orvatez®
Active Substance
Ezetimibe and Atorvastatin
Therapeutic Area
Cardiovascular
License
License from MSD
Tryptizol®
Active Substance
Amitriptyline hydrochloride
Therapeutic Area
Central nervous system
License
ROVI propietary product
Ulunar®
Breezhaler®
Active Substance
Indacaterol maleate and
glycopyrronium bromide
Therapeutic Area
Pneumology
License
License from Novartis Europharm Limited
Volutsa®
Active Substance
Solifenacin succinate and tamsulosin hydrochloride
Therapeutic Area
Urology
License
License from Astellas Pharma